Downloads provided by UsageCountsIncreasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
Symptomatic treatment of myasthenia gravis is based on the use of peripherally-acting acetylcholinesterase (AChE) inhibitors that, in some cases, must be discontinued due to the occurrence of a number of side-effects. Thus, new AChE inhibitors are being developed and investigated for their potential use against this disease. Here, we have explored two alternative approaches to get access to peripherally-acting AChE inhibitors as new agents against myasthenia gravis, by structural modification of the brain permeable anti-Alzheimer AChE inhibitors tacrine, 6-chlorotacrine, and huprine Y. Both quaternization upon methylation of the quinoline nitrogen atom, and tethering of a triazole ring, with, in some cases, the additional incorporation of a polyphenol-like moiety, result in more polar compounds with higher inhibitory activity against human AChE (up to 190-fold) and butyrylcholinesterase (up to 40-fold) than pyridostigmine, the standard drug for symptomatic treatment of myasthenia gravis. The novel compounds are furthermore devoid of brain permeability, thereby emerging as interesting leads against myasthenia gravis.
Models, Molecular, Malalties neuromusculars, [SDV.BBM.BS] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], [CHIM.THER] Chemical Sciences/Medicinal Chemistry, 610, quinolinium compounds, Organic chemistry, Down-Regulation, [CHIM.THER]Chemical Sciences/Medicinal Chemistry, GPI-Linked Proteins, Heterocyclic Compounds, 4 or More Rings, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Article, copper-catalyzed azide-alkyne cycloaddition, Structure-Activity Relationship, QD241-441, Myasthenia Gravis, structural biology, Humans, triazoles, Molecular Structure, Molecular Biology/Structural Biology [q-bio.BM], Aminoacridines, acetylcholinesterase inhibitors; butyrylcholinesterase inhibitors; quinolinium compounds; triazoles; structural biology; copper-catalyzed azide-alkyne cycloaddition; click chemistry;, acetylcholinesterase inhibitors; butyrylcholinesterase inhibitors; quinolinium compounds; triazoles; structural biology; copper-catalyzed azide-alkyne cycloaddition; click chemistry, Triazoles, Acetilcolinesterasa, Neuromuscular diseases, acetylcholinesterase inhibitors, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Butyrylcholinesterase, click chemistry, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Acetylcholinesterase, Aminoquinolines, Tacrine, butyrylcholinesterase inhibitors, Cholinesterase Inhibitors
Models, Molecular, Malalties neuromusculars, [SDV.BBM.BS] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], [CHIM.THER] Chemical Sciences/Medicinal Chemistry, 610, quinolinium compounds, Organic chemistry, Down-Regulation, [CHIM.THER]Chemical Sciences/Medicinal Chemistry, GPI-Linked Proteins, Heterocyclic Compounds, 4 or More Rings, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Article, copper-catalyzed azide-alkyne cycloaddition, Structure-Activity Relationship, QD241-441, Myasthenia Gravis, structural biology, Humans, triazoles, Molecular Structure, Molecular Biology/Structural Biology [q-bio.BM], Aminoacridines, acetylcholinesterase inhibitors; butyrylcholinesterase inhibitors; quinolinium compounds; triazoles; structural biology; copper-catalyzed azide-alkyne cycloaddition; click chemistry;, acetylcholinesterase inhibitors; butyrylcholinesterase inhibitors; quinolinium compounds; triazoles; structural biology; copper-catalyzed azide-alkyne cycloaddition; click chemistry, Triazoles, Acetilcolinesterasa, Neuromuscular diseases, acetylcholinesterase inhibitors, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Butyrylcholinesterase, click chemistry, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Acetylcholinesterase, Aminoquinolines, Tacrine, butyrylcholinesterase inhibitors, Cholinesterase Inhibitors
7 Research products, page 1 of 1
- 2013IsAmongTopNSimilarDocuments
- 2018IsRelatedTo
- 2018IsSupplementTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).33 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10% visibility views 85 download downloads 46 - 85views46downloads
Views provided by UsageCounts
Downloads provided by UsageCounts
